MATINAS BIOPHARMA Investors
Matinas BioPharma is a biopharmaceutical company based in Tarpon Springs, Florida, founded in 2011 The company specializes in developing innovative therapies through its proprietary lipid-crystal nano-delivery platform Matinas BioPharma has attracted significant investment, securing substantial funding to advance its research and development initiatives The organization is dedicated to addressing unmet medical needs and enhancing patient outcomes through its novel drug delivery systems With a strong focus on collaboration, Matinas BioPharma actively engages with accelerators and incubators to foster innovation in the biopharmaceutical sector
Headquarters:
USA
Technology:
Immunotherapy
Estimated Revenue:
$1B to $10B
Founded Date:
2011
Investor Type:
Accelerators and Incubators
Industry:
FemTech